Rxcare Pharmaceutical Private Limited - Due diligence report

A 360° intelligence report on Rxcare Pharmaceutical Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2012-05-21 Jaipur, Rajasthan Strike Off Unlisted Active Non-Compliant
Share
Connect MCP
RP Rxcare Pharmaceutical Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Rxcare Pharmaceutical Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
53/100
Trust Score
Moderate

Rxcare Pharmaceutical Private Limited is assessed as Moderate with a Trust Score of 53/100. Rxcare Pharmaceutical Private Limited is a private limited indian non-government company incorporated in 2012, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 08 Aug 2026 from the latest processed filings. Rxcare Pharmaceutical Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
53/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
10/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 10/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
HIMANSHU GUPTA 01234567 Director 01/04/2018 6 yrs Approved
VINOD KUMAR PANCHOLI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • HIMANSHU GUPTA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 5 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 14+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (10/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence36/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment67/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view41/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
31 Mar 2016
Share transfer (FY 2016)
2000.00000000 shares to Himanshu
Share transfer (FY 2016)
2000.00000000 shares to Kumar Vinod
Share transfer (FY 2016)
1000.00000000 shares to Kumar Vinod
Share transfer (FY 2016)
1000.00000000 shares to Himanshu
09 Oct 2015
Director ceased
DEEPMANI SWARANKAR
08 Oct 2015
Director appointed
HIMANSHU GUPTA (Director)
08 Sep 2015
Director ceased
ANIL KUMAR SHARMA
Director ceased
MANISH TIWARI
Director ceased
HIMANSHU KHANDELWAL
21 May 2012
Incorporated
Registered with Roc Jaipur
Director appointed
VINOD KUMAR PANCHOLI (Director)
10

Key Observations

Auto-generated from the data above
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
C K Impex Private Limited U51909DL2003PTC122959 New Delhi, Delhi, India
Chant Merchants Pvt Ltd U74999JH1994PTC025727 Hazaribagh, Jharkhand, India
Angela Commodities Private Limited. U51109WB2007PTC121092 Kolkata, West Bengal, India
Bharti Software Private Limited U72900RJ2013PTC043053 Beawar, Rajasthan, India
Kesaria Commercial Company Private Limited U74900WB2010PTC156331 Howrah, West Bengal, India
Garnet Linkers Private Limited U52100DL2014PTC265449 New Delhi, Delhi, India
Burrabazar Commercial Pvt Ltd U51109WB1990PTC050072 Kolkata, West Bengal, India
J.M & Sons Paper Vocation Private Limited U21000MH2016PTC273138 Jalgaon, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Rxcare Pharmaceutical Private Limited before audits and certifications: compliance score 10/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Rxcare Pharmaceutical Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Rxcare Pharmaceutical Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 53/100, distress signals and MSME payment-delay disclosures - know whether Rxcare Pharmaceutical Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Rxcare Pharmaceutical Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Rxcare Pharmaceutical Private Limited an active company?

Rxcare Pharmaceutical Private Limited has MCA status “Strike Off” with a compliance score of 10/100 (Caution Indicated).

Is Rxcare Pharmaceutical Private Limited financially healthy?

Rxcare Pharmaceutical Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Rxcare Pharmaceutical Private Limited?

Its overall Trust Score is 53/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Rxcare Pharmaceutical Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Rxcare Pharmaceutical Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Rxcare Pharmaceutical Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 10/100 (Caution Indicated).

Is it risky to lend to Rxcare Pharmaceutical Private Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.